Who owns NEWAMSTERDAM PHARMA CO NV?
- Ticker: NAMSW
- CUSIP Number: n62509117
Tip: Access positions for across all investors
Analyze quarterly positions in Newamsterdam Pharma Co Nv with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Newamsterdam Pharma Co Nv stock
Who bought or sold NEWAMSTERDAM PHARMA CO NV this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Frazier Life Sciences Management | 500k | $10M | 0% | Mar 2026 |
|
| RA Capital Management | 333k | $6.7M | 0% | Mar 2026 |
|
| Affinity Asset Advisors | 245k | $5.6M | 0% | Dec 2025 |
|
| Bain Capital Life Sciences Investors | 100k | $2.0M | 0% | Mar 2026 |
|
| Deerfield Management Company | 93k | $1.9M | 0% | Mar 2026 |
|
| Millennium Management | 75k | $1.5M | 0% | Mar 2026 |
|
| Aristeia Capital | 16k | $343k | 0% | Mar 2026 |
|
| Vestcor Investment Management Corp | 6.7k | $131k | -31% | Mar 2026 |
|
| Wolverine Asset Management | 2.1k | $43k | 100% | Mar 2026 |
|
| Atlantic Trust | 1.0k | $25k | -20% | Dec 2025 |
|
| UBS Group | 396.00 | $7.9k | 0% | Mar 2026 |
|
Who sold out of Newamsterdam Pharma Co Nv?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Laurion Capital Management | Sep 2025 | 17k | $285k |